Abstract:UNLABELLED:Cisplatin resistance is a major problem affecting ovarian carcinoma treatment. NF-E2-related factor 2 (Nrf2), a nuclear transcription factor, plays an important role in chemotherapy resistance. However, the underlying mechanism by which Nrf2 mediates cisplatin chemoresistance is unclear.METHODS:The human ovarian carcinoma cell line, A2780, and its cisplatin-resistant variant, A2780cp were cultivated. Cell viability was determined with WST-8 assay. Western blot was applied to detect the expression of Nrf2, Nrf2 target genes, and autophagy-related proteins. RNA interference was used to knock down target genes. Annexin V and propidium iodide (PI) staining was utilized to quantify apoptosis. The ultrastructural analysis of autophagosomes was performed by transmission electron microscopy (TEM).RESULTS:Nrf2 and its targeting genes, NQO1 and HO-1, are overexpressed in A2780cp cells compared with A2780 cells. Knocking down Nrf2 sensitized A2780cp cells to cisplatin treatment and decreased autophagy-related genes, Atg3, Atg6, Atg12 and p62 in both mRNA and protein levels. Furthermore, we demonstrated that in both cell lines cisplatin could induce the formation of autophagosomes and upregulate the expression of autophagy-related genes Atg3, Atg6 and Atg12. Treatment with an autophagy inhibitor, 3-Methyladenine (3-MA), or beclin 1 siRNA enhanced cisplatin-induced cell death in A2780cp cells, suggesting that inhibition of autophagy renders resistant cells to be more sensitive to cisplatin. Taken together, Nrf2 signaling may regulate cisplatin resistance by activating autophagy.CONCLUSIONS:Nrf2-activated autophagy may function as a novel mechanism causing cisplatin-resistance.

Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells

A New Strategy of Promoting Cisplatin Chemotherapeutic Efficiency by Targeting Endoplasmic Reticulum Stress.

Er Stress and Autophagy Are Involved in the Apoptosis Induced by Cisplatin in Human Lung Cancer Cells

Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Targeting Endoplasmic Reticulum Stress by Natural and Chemical Compounds Ameliorates Cisplatin-Induced Nephrotoxicity: A Review

Inhibition of Autophagy Enhances Cisplatin Cytotoxicity Through Endoplasmic Reticulum Stress in Human Cervical Cancer Cells

Targeting UPR branches, a potential strategy for enhancing efficacy of cancer chemotherapy

Cisplatin-activated ERβ/DCAF8 Positive Feedback Loop Induces Chemoresistance in Non-Small Cell Lung Cancer Via PTEN/Akt Axis

Crosstalk between endoplasmic reticulum stress and multidrug-resistant cancers: hope or frustration

Endoplasmic Reticulum Quality Control in Cancer: Friend or Foe.

New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment

Nrf2 Induces Cisplatin Resistance Through Activation of Autophagy in Ovarian Carcinoma.

Role of Nucleotide Excision Repair in Cisplatin Resistance

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux

Failure of Elevating Calcium Induces Oxidative Stress Tolerance and Imparts Cisplatin Resistance in Ovarian Cancer Cells.

Autophagy Inhibition Impairs the Epithelial-Mesenchymal Transition and Enhances Cisplatin Sensitivity in Nasopharyngeal Carcinoma

Drug Resistance and Endoplasmic Reticulum Stress in Hepatocellular Carcinoma

[Relationship Between ERCC1 Expression and Cisplatin Intervention in Human Lung Adenocarcinoma Cell Lines].

Endoplasmic Reticulum Stress Induced Autophagy in Cancer and Its Potential Interactions with Apoptosis and Ferroptosis.

Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment